- Investing Ideas
- /
- Utilities Healthcare Sector
Utilities Healthcare Sector
Results
2249
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2249 companies
Xenon Pharmaceuticals
Market Cap: US$3.1b
A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.
XENE
US$39.64
7D
0.2%
1Y
-5.1%
Ansell
Market Cap: AU$4.7b
Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.
ANN
AU$32.48
7D
0.5%
1Y
1.8%
Ultragenyx Pharmaceutical
Market Cap: US$3.0b
A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.
RARE
US$31.45
7D
4.2%
1Y
-44.0%
Prestige Consumer Healthcare
Market Cap: US$3.0b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$61.00
7D
-3.5%
1Y
-13.0%
Centessa Pharmaceuticals
Market Cap: US$3.0b
A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.
CNTA
US$22.31
7D
-3.0%
1Y
33.9%
Immunovant
Market Cap: US$3.0b
A clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases.
IMVT
US$17.03
7D
2.9%
1Y
-42.2%
Indivior
Market Cap: US$3.0b
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
INDV
US$23.78
7D
4.6%
1Y
201.0%
Tarsus Pharmaceuticals
Market Cap: US$3.0b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$70.14
7D
3.6%
1Y
92.3%
Privia Health Group
Market Cap: US$3.0b
Operates as a national physician-enablement company in the United States.
PRVA
US$24.08
7D
-0.2%
1Y
35.6%
Perrigo
Market Cap: US$2.9b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$21.25
7D
-3.6%
1Y
-12.1%
Cidara Therapeutics
Market Cap: US$2.9b
Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.
CDTX
US$113.05
7D
17.2%
1Y
997.6%
ICU Medical
Market Cap: US$2.8b
Develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide.
ICUI
US$114.13
7D
-6.0%
1Y
-36.7%
Kiniksa Pharmaceuticals International
Market Cap: US$2.8b
A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.
KNSA
US$37.89
7D
-1.0%
1Y
42.3%
HeartFlow
Market Cap: US$2.8b
A medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide.
HTFL
US$33.47
7D
-10.2%
1Y
n/a
LivaNova
Market Cap: US$2.8b
A medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide.
LIVN
US$50.69
7D
-3.7%
1Y
-5.8%
Supernus Pharmaceuticals
Market Cap: US$2.7b
A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$49.00
7D
1.4%
1Y
48.8%
Veracyte
Market Cap: US$2.7b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$34.80
7D
-3.4%
1Y
2.6%
HUTCHMED (China)
Market Cap: UK£2.0b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
HCM
UK£2.32
7D
-0.9%
1Y
-20.8%
Semnur Pharmaceuticals
Market Cap: US$2.6b
Develops and markets non-opioid drugs to treat back pain.
SMNR
US$9.00
7D
0%
1Y
-21.8%
Intellia Therapeutics
Market Cap: US$2.6b
A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.
NTLA
US$24.52
7D
19.4%
1Y
25.7%
Concentra Group Holdings Parent
Market Cap: US$2.6b
Provides occupational health services in the United States.
CON
US$20.31
7D
-1.6%
1Y
-3.1%
Belite Bio
Market Cap: US$2.6b
A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States.
BLTE
US$79.28
7D
1.5%
1Y
42.1%
Beam Therapeutics
Market Cap: US$2.6b
A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.
BEAM
US$26.32
7D
1.7%
1Y
-1.0%
Alvotech
Market Cap: US$2.6b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$8.24
7D
-4.0%
1Y
-34.1%
Amicus Therapeutics
Market Cap: US$2.6b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$8.30
7D
1.7%
1Y
-20.3%
Surgery Partners
Market Cap: US$2.5b
Owns and operates a network of surgical facilities and ancillary services in the United States.
SGRY
US$19.74
7D
-3.2%
1Y
-37.8%
Ocular Therapeutix
Market Cap: US$2.5b
A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
OCUL
US$11.78
7D
7.4%
1Y
12.6%
Organon
Market Cap: US$2.5b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$9.60
7D
-11.4%
1Y
-47.0%
Catalyst Pharmaceuticals
Market Cap: US$2.5b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$20.36
7D
-1.8%
1Y
-1.4%
Disc Medicine
Market Cap: US$2.4b
A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.
IRON
US$69.90
7D
0.9%
1Y
45.7%
Arcutis Biotherapeutics
Market Cap: US$2.4b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$20.05
7D
1.5%
1Y
105.9%
GRAIL
Market Cap: US$2.4b
A commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.
GRAL
US$66.13
7D
7.2%
1Y
376.8%
DENTSPLY SIRONA
Market Cap: US$2.4b
Develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.
XRAY
US$11.83
7D
-5.5%
1Y
-51.6%
Agios Pharmaceuticals
Market Cap: US$2.4b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO
US$40.61
7D
-0.7%
1Y
-1.6%
Mesoblast
Market Cap: AU$3.6b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.82
7D
8.9%
1Y
95.8%
Haemonetics
Market Cap: US$2.4b
A medical technology company, provides a suite of hospital technologies solutions in the United States and internationally.
HAE
US$48.85
7D
-1.4%
1Y
-35.1%